PT  - JOURNAL ARTICLE
AU  - Yamamoto, Shohei
AU  - Mizoue, Tetsuya
AU  - Tanaka, Akihito
AU  - Oshiro, Yusuke
AU  - Inamura, Natsumi
AU  - Konishi, Maki
AU  - Ozeki, Mitsuru
AU  - Miyo, Kengo
AU  - Sugiura, Wataru
AU  - Sugiyama, Haruhito
AU  - Ohmagari, Norio
TI  - Sex–associated differences between body mass index and SARS-CoV-2 antibody titers following the BNT162b2 vaccine among 2,435 healthcare workers in Japan
AID  - 10.1101/2021.08.30.21262862
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.08.30.21262862
4099  - http://medrxiv.org/content/early/2021/09/01/2021.08.30.21262862.short
4100  - http://medrxiv.org/content/early/2021/09/01/2021.08.30.21262862.full
AB  - Obesity may downregulate vaccine-induced immunogenicity, but the epidemiological evidence for the COVID-19 vaccine is limited, and the sex-associated difference is unknown. It was observed that a higher body mass index was associated with lower titers of spike IgG antibodies against SARS-CoV-2 in men but not in women.Competing Interest StatementAntibody assay reagent was provided by Abbott Japan.Funding StatementThis work was supported by the NCGM COVID-19 Gift Fund (grant number 19K059) and the Japan Health Research Promotion Bureau Research Fund (grant number 2020-B-09).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study procedure was approved by the ethics committee of the National Center for Global Health and Medicine, Japan.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and/or analyzed during the current study are not publicly available due to ethical restrictions and participant confidentiality concerns, but de-identified data are available from the corresponding author to qualified researchers on reasonable request.